# KALA BIO, Inc.: Form SCHEDULE 13D/A, filed Oct 2, 2025

- Company: [KALA BIO, Inc.](/companies/kala.md) (CIK 1479419)
- Form: SCHEDULE 13D/A
- Filed: 2025-10-02
- Accepted by EDGAR: Oct 2, 2025, 20:37 ET
- Period: not reported
- Accession: 0001104659-25-096281
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1479419/000110465925096281/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1479419/000110465925096281/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1479419/000110465925096281/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Oct 2, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-096281. Last ingested by Listed: Nov 3, 2026, 19:22 ET. No prices; not investment advice.